Agoracom Blog Home

Author Archive

ZeUPay: Groundbreaking P2P Payment Provider & #Crypto to Fiat Gateway – $ZEU.ca Technologies $MOS.ca $MOGO.ca CTZ.ca $TRAD.ca

Posted by AGORACOM-JC at 7:26 AM on Monday, January 18th, 2021
  • Completed its exhaustive due diligence review and corporate integration documentation and expects delivery of final legal opinions in relation to the proposed acquisition of Prego International Group AS.
  • ZeUPay will be fully integrated into the Mula ecosystem.
  • Users of ZeU and the Mula platform native function and applications, as well as users of third-party developed applications, will be able to use its Crypto to Fiat gateway functionalities.

Montréal – January 17, 2021 – ZeU Technologies Inc. (CSE:ZEU) (CNSX:ZEU.CN) is pleased to announce that it has completed its exhaustive due diligence review and corporate integration documentation and expects delivery of final legal opinions in relation to the proposed acquisition of Prego International Group AS.

Management of both companies plan to sign the final acquisition documents later this week. It is expected that all regulatory review should be completed on or around February 5,  2021.  At that point, all shares of Prego International would have been exchanged for convertible debentures of ZeUPay, a wholly owned subsidiary of ZeU Technologies and the target corporation.

Ronald Eriksen will join the board of directors of ZeU Technologies at closing.

ZeUPay will be fully integrated into the Mula ecosystem. Users of ZeU and the Mula platform native function and applications, as well as users of third-party developed applications, will be able to use its Crypto to Fiat gateway functionalities.  All current account holders of Prego, including Pay2Go card holders, will be seamlessly migrated to a Mula digital wallet that will allow them to send or receive money, lend to the ecosystem, earn income and interest, and structure transactions. ZeUPay’s utility token will be hot-swappable with a range of other tokens, including the MulaPay stable utility token.

Source: https://agoracom.com/ir/ZeUTechnologies/forums/discussion/topics/753243-zeupay-groundbreaking-p2p-payment-provider-crypto-to-fiat-gateway/messages/2298541#message

Valeo Pharma $VPH.ca $VPHIF Announces Major Addition to its Senior Management Team $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 7:14 AM on Monday, January 18th, 2021
Valeo Pharma (@valeo_pharma) | Twitter
  • Frederic Fasano named President and COO
  • Steve Saviuk continues as CEO and becomes Vice-Chairman of the Board of Directors

MONTREAL , Jan. 18, 2021 – Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (” Valeo ” or the ” Company “), a Canadian pharmaceutical company, announced today the appointment of Mr. Frederic Fasano to the newly created position of President and Chief Operating Officer, effective January 18th , to augment its senior leadership team and support expansion of Valeo’s commercial activities. Mr. Fasano has also been elected to the Company’s Board of Directors effective as of today.

“It gives me true pleasure to welcome Frederic to the Valeo executive team in this important new role. He possesses extensive International pharmaceutical experience and his management skills are well suited to helping us build a leading innovative pharmaceutical company with a deep commitment to our selected therapeutic areas of focus”, said Steve Saviuk,  CEO. “This increase in management depth, coupled with our solid foundation of products and people, positions us well for the dynamic growth we foresee in the coming years.”

Read More: https://agoracom.com/ir/ValeoPharma/forums/discussion/topics/753244-valeo-pharma-announces-major-addition-to-its-senior-management-team/messages/2298542#message

VIDEO – Loop Insights $MTRX.ca $RACMF Begins 2021 With 4 Big Developments And CEO Rob Anson Reaffirms 2021 Shaping Up To Be Company’s Biggest $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:00 AM on Monday, January 18th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

In our December 30 Interview with Loop Insights (MTRX:TSXV /  RACMF:OTCQB) CEO Rob Anson titled 2021 “A Year Of Major Growth and Expansion”, two quotes from him stood out above all:

When we look back at 2020 this time next year … what we’ve done is very little in my opinion to date.”

Wait … What?

“This year (2021) will see major growth and expansion …. We’re about to reap the rewards from all the groundwork and that is exciting to me … This will be our biggest year by a country mile”

Given the fact we had to do this interview on a Sunday due to Anson “putting in 100 work weeks” and “18-20 Zoom presentations per day”,  as well as, 4 pretty significant press releases in the first 2 weeks of 2021, Anson is living up to his word.

Moreover, in this interview, he shows no hesitation when asked if he still feels the same way about 2021.

Watch this great Sunday morning interview with Loop Insights Founder and CEO, Rob Anson.

VIDEO – FansUnite Entertainment $FANS.ca $FUNFF Closes $13.4M Financing – That Started At Just $5,000,000. Find Out Why! $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 7:00 AM on Monday, January 18th, 2021

FansUnite Entertainment $FANS $FUNFF continues to live up to its name as the “Small Cap iGaming Super Company” by yet again announcing major news.

Specifically, their originally announced $5M financing was upsized to $11,000,000 …. and then upsized AGAIN to $13,400,000.  And according to CEO Scott Burton, the demand was much higher but they had to make a decision to cut it off at some point.

This should tell you all you need to know about how much demand there is for this small cap online gambling company, who recently made history by becoming the first EVER dedicated esports sportsbook in the United States, along with partner GameCo.

What we love about the Company is having both B2C (direct gambling customers) and B2B (providing the world’s online casinos with new games and technology).

Moreover, they were granted their all important Malta license recently, are now pursuing the invaluable UK license and finally, appear to be in pole position for anticipated changes to online gambling laws in Canada later in 2021.

Watch this amazing interview with $FANS CEO, Scott Burton

PlantX $VEGA.ca $PLTXF Announces Partnership with Cosmetic Brand Nootka & Sea $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 8:39 AM on Friday, January 15th, 2021
  • Entered into a strategic partnership with Nootka & Sea, a privately held British Columbia company that carries on the business of apothecary and cosmetics.
  • The addition of Nootka allows PlantX to further expand its category verticals.
  • Nootka’s products will be available to order in the Beauty section of the Company’s Canadian and U.S. e-commerce platforms, www.PlantX.ca and www.PlantX.com , this coming week.

VANCOUVER, British Columbia, Jan. 15, 2021 — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (” PlantX ” or the ” Company “) is pleased to announce it has entered into a strategic partnership with Nootka & Sea (” Nootka “), a privately held British Columbia company that carries on the business of apothecary and cosmetics.

The addition of Nootka allows PlantX to further expand its category verticals. Nootka’s products will be available to order in the Beauty section of the Company’s Canadian and U.S. e-commerce platforms, www.PlantX.ca and www.PlantX.com , this coming week.

Nootka’s “Nootka & Sea” is a lifestyle brand with a West Coast feel. The brand complements the PlantX identity and expands the Company’s current verticals and partnerships. PlantX is well positioned to take advantage of this growing plant-based beauty and cosmetics market.

“We are aiming to be the digital face of the plant-based community, and as such we want to be able to carry and offer the very highest-quality products for our customers,” said Sean Dollinger, PlantX founder. “This partnership will help us capitalize on this exciting market.”

Source: https://agoracom.com/ir/PlantX/forums/discussion/topics/753100-plantx-announces-partnership-with-cosmetic-brand-nootka-sea/messages/2298110#message

VIDEO – After Record Q3 and YTD Results, Datametrex $DM.ca $DTMXF Starts 2021 With 23,000 #COVID Test Sales To Film Industry For ~ $4M $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 8:34 PM on Thursday, January 14th, 2021

Datamerex (DM:TSXV) has the rare benefit that most small cap companies would only dream of …. 2 successful independent divisions that are each capable of being a company maker. 

The first division is their Artificial Intelligence driven social media monitoring and discovery product … and this isn’t some basic social media monitoring tool for keywords. Clients include Canadian Federal Government, DRDC, Health Canada, United States Air Force and LOTTE (a $2.6B South Korean multinational conglomerate.

As a result of the highest level security clearances required to do this level of work, Datametrex was well positioned with deep roots in South Korea to add their second, though unintended division of COVID-19 test kit distribution.  Again, this isn’t some small cap stretch trying to capitalize on a trend for the sake of stock promotion. Rather, when the Canadian Government came calling for assistance in importing and distributing COVID-19 test kits, Datametrex stepped up to the task thanks to its security clearances already in place in both countries.

Since then, the company has signed multiple multi-million dollar COVID-19 test kit supply agreements with mining companies, a $20M CAD agreement with the television and film industry and various educational institutions.  

As a result, Datametrex has had its’ best year ever in the first 3 quarters of 2020 as follows:

  • Record revenue of $7.6 million for the nine-month 2020 period compared to $2.6 in 2019
  • Record revenue of $4.9 million was generated in Q3
  • First ever positive EBIDTA quarter

If that wasn’t enough, they started off 2021 by announcing the following:

  • Sold over 23,000 onsite tests for the film industry at locations in Montreal, Toronto and Vancouver for the months of October through December 2020. This represents approximately $4,000,000 CAD in top-line revenue for Q4
  • Datametrex Providing COVID-19 Testing for Air Canada Front-Line and Inflight Employees
  • Binding LOI to acquire 100% of Concierge Medical Consultant Inc. a private telehealth and medical concierge services company currently generating revenue through a direct-to-consumer subscription model

Watch this powerful interview with CEO Marshall Gunter to discuss the year that was … and why he’s so optimistic about 2021.

Sheldon Inwentash $IDK.ca $IDKFF Discusses The Digitization Shock Happening In Canada And His Experience Investing In New Technologies $IP.ca $IPNFF $PKK.ca $PKKFF $MTRX $RACMF

Posted by AGORACOM-JC at 4:50 PM on Thursday, January 14th, 2021
IDK-square-for-blog

Entrepreneur Sheldon Inwentash is the founder and President of Toronto’s ThreeD Capital, a venture capital firm focused on investments in companies operating in junior resources, blockchain, artificial intelligence, psychedelics, electric vehicles and other sectors.

For Sheldon, a career that began in the life insurance industry as an oil and gas analyst quickly evolved into one that would include the creation of five companies and nine CEO roles, including a 20-year stay as the founder of Pinetree Capital.

In addition to providing companies with investment strategies, Sheldon provides counsel and guidance to C-suite executives. He has financed hundreds of public and private start-up companies, many of which went on to have successful exits.

We recently spoke with Sheldon about the digitization shock happening in Canada and his experience with investing in new technology.

During COVID, all you have to do is turn on the news to learn about the various digital strategies that companies have had to implement. Do you think digitization will continue to impact the way businesses operate, even after the pandemic is over?

Sheldon Inwentash: Yes. COVID definitely accelerated digitization, but I believe that whether there was a pandemic or not, we were going to see it happen. Even after COVID is over, people will be more embedded in working remotely and going through the digital mechanics. Whether it’s through a ZOOM call or shifting your business to eCommerce, my feeling is that we are in the midst of a digital acceleration, and this way of life will be with us indefinitely.

The stock market is at an all time high and junior cap stocks are on a tear. How do you think the digital revolution influenced this?

Sheldon Inwentash: There are a lot of digital technology stocks that are on the rise. There are also a lot of companies that, because of people having to purchase items online, have seen a sharp increase in stocks. I think the market is also discounting a pent-up demand on many fronts. Whether it’s the anticipation of airline stocks, oil and gas stocks, the green revolution – I think it’s a great time to be an investor because there are so many different verticals that are exciting and interesting to invest in. Frankly, I see this continuing over the long term.

ThreeD Capital invests in a range of industries, including blockchain technology, electric vehicles and AI. What about the future of technology piques your interest when it comes to making investment decisions?

Sheldon Inwentash: We have a number of disruptive technologies in our portfolio. These are technologies that change the way we do things or are different from what we’ve done before. They’re more efficient to use. Technology is an integral part of our investment philosophy and we are actively looking on a weekly basis at new emerging technology companies that we think have a chance for exponential growth.

A tech entrepreneur comes to you asking for capital. What do you expect from them in terms of a pitch?

Sheldon Inwentash: I want to hear a clear, concise message. From there, obviously, there’s depth of technology and infrastructure. Time is your enemy in this business. Even before we listen to a pitch, we prefer to get a PowerPoint presentation in advance because then we are able to determine whether or not it’s something that interests us. In some cases, even the PowerPoint isn’t so clear, but we may still be interested. In that case, we expect the founder to be able to communicate in a very succinct and fast matter or otherwise it tends to lose our focus.

What, in terms of venture capital, can investors do to help make Toronto the next Silicon Valley?

Sheldon Inwentash: I think Toronto is underrated in the amount of tech that I see evolving in the city. Anytime you have a number of universities and teaching and research centers within an hour outside of Toronto, which we do, those are the places that spawn all the R&D. Those are the places that come up with great new things.

People are leaving Silicon Valley. There are Silicon Valley’s in every city now because of the digital revolution. Anyone can work, from anywhere, whenever they want now. There’s really no barrier to entry.

In the blockchain space, Toronto is a global leader, but it’s not understood that that’s the case. The only thing that’s missing is capital, but there’s a lot of that in Toronto, as well, so there are opportunities everywhere. Arguably, Toronto doesn’t have to be a Silicon Valley of the north, but it does have its fair share of companies that are spawned here.

Source: https://www.finsmes.com/2021/01/threed-capital-interview-with-founder-chairman-and-ceo-sheldon-inwentash.html

Innocan Pharma $INNO.ca Successfully Completes Large Scale Production of Exosomes $IN.ca $AXIM $LABS $CRDL.ca $TBP.ca

Posted by AGORACOM-JC at 4:15 PM on Thursday, January 14th, 2021
Innocan-Blog
  • Announced the successful completion of a large-scale production of exosomes
  • Innocan’s CBD Loaded Exosome (CLX) Therapy project led by Prof. Offen demonstrates the capability of having reliable large-scale production of exosomes and is an important milestone in the CLX Therapy development process.
  • Innocan managed to perform the production of trillions of exosomes in a short period of time in a 3-dimensional bioreactor, and that may lead to economic large scale exosome production for the CLX.
  • This achievement is expected to pave the way for larger tests and studies.

Herzliya, Israel and Calgary, Alberta–(January 14, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the “Company” or “Innocan“), is pleased to announce the successful completion of a large-scale production of exosomes. Innocan’s CBD Loaded Exosome (CLX) Therapy project led by Prof. Offen demonstrates the capability of having reliable large-scale production of exosomes and is an important milestone in the CLX Therapy development process. Innocan managed to perform the production of trillions of exosomes in a short period of time in a 3-dimensional bioreactor, and that may lead to economic large scale exosome production for the CLX. This achievement is expected to pave the way for larger tests and studies.

“Innocan is now one of a few public companies in the exosome’s science field. Although we are still in the development stage of the CLX platform, large scale exosome production capabilities are a significant proof of advantage and capability for Innocan, as part of the path to commercialization,” said Iris Bincovich, founder and CEO of Innocan.

Innocan Pharma together with Tel Aviv University, Prof. Offen and his team, are developing a new revolutionary cell therapy – based technology, loaded with CBD (Cannabidiol), designed to target coronavirus infected lung cells and central nervous system diseases. The CLX Therapy holds the potential to provide a highly synergistic effect of anti-inflammatory properties and help in the recovery of infected lung cells. This product is planned to act as a “guided missile” to the infected lungs, combining the cell healing properties of exosomes and the anti-inflammatory properties of CBD.

AGORACOM Small Cap 60: Valeo Pharma $VPH.ca $VPHIF Discusses Health Canada Approval for Redesca™ and Redesca Hp™ $30 Million Forecasted Annual Peak Sales $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 12:14 PM on Thursday, January 14th, 2021
Valeo Pharma (@valeo_pharma) | Twitter
  • Commercial launch to impact first half 2021 revenue
  • $30 million forecasted annual peak sales
  • 8 years of proven in-market safety Internationally
  • Low molecular weight heparin increasingly used to prevent COVID-19 driven complications

“The regulatory approval of Redesca is a significant corporate milestone for Valeo and also great news for the Canadian healthcare system. Mandatory use of biosimilars is increasingly  being adopted across the country and is expected to help provide significant savings to provincial healthcare plans”, said Steve Saviuk , President and CEO. “With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement of our growth objectives”.

Hub On AGORACOM / Corporate Profile

PlantX $VEGA.ca $PLTXF Announces Monthly Gross Revenue of $1,029,883 for December 2020 $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 8:37 AM on Thursday, January 14th, 2021

  • Announced that it achieved record monthly gross revenue of $1,029,883 for the month of December 2020.
  • November and December to the exceptional branding, marketing and partnerships that the Company has been able to establish over the past 12 months.
  • The revenue figures demonstrate the viability of the Company’s business model and its successful ability to reach its target consumer market.

VANCOUVER, British Columbia, Jan. 14, 2021  — PlantX Life Inc. (the “Company” or “PlantX”) (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is pleased to announce that it achieved record monthly gross revenue of $1,029,883 for the month of December 2020.

For the month of November 2020, the Company achieved gross revenue of approximately $640,000. The Company attributes the increased revenue between November and December to the exceptional branding, marketing and partnerships that the Company has been able to establish over the past 12 months. The revenue figures demonstrate the viability of the Company’s business model and its successful ability to reach its target consumer market.

“2020 has been a trying year for all of us, but our Company is seeing incredible growth and some of the benefits due to the stay-at-home environment. In December 2019, we had essentially zero sales revenue. To go from zero revenue per month to $1million in revenue a month is a huge feat and a massive milestone for the Company. I also want to bring up the incredible growth we’re seeing on a month-to-month basis growing 60% in December from November. The Company has some new marketing initiatives in store for 2021, and we’re excited to continue our success!’’ stated PlantX CEO Julia Frank.

Read More: https://agoracom.com/ir/PlantX/forums/discussion/topics/753007-plantx-announces-monthly-gross-revenue-of-1-029-883-for-december-2020/messages/2297841#message